Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

Ratner, R. E. ; Rosenstock, J. ; Boka, G.

Diabetic medicine, 2010-09, Vol.27 (9), p.1024-1032 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível